摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 1-(2-chloroethylamino)-1-oxo-3-phenylpropan-2-ylcarbamate | 1579223-88-3

中文名称
——
中文别名
——
英文名称
tert-butyl 1-(2-chloroethylamino)-1-oxo-3-phenylpropan-2-ylcarbamate
英文别名
tert-butyl N-[(2S)-1-(2-chloroethylamino)-1-oxo-3-phenylpropan-2-yl]carbamate
tert-butyl 1-(2-chloroethylamino)-1-oxo-3-phenylpropan-2-ylcarbamate化学式
CAS
1579223-88-3
化学式
C16H23ClN2O3
mdl
——
分子量
326.823
InChiKey
NQWKWBMELOCLQL-ZDUSSCGKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    22
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    67.4
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl 1-(2-chloroethylamino)-1-oxo-3-phenylpropan-2-ylcarbamate 在 sodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 6.0h, 以81%的产率得到2-(N-Boc-1-amino-2-phenethyl)-2-oxazoline
    参考文献:
    名称:
    具有侧链l-脯氨酰胺部分的新型聚(2-恶唑啉),可作为直接不对称羟醛反应的有效有机催化剂†
    摘要:
    聚(2-恶唑啉)负载的双功能有机催化剂已通过自下而上的方法制备,该方法涉及合成明确定义的侧链中带有氨基的聚(2-恶唑啉)前体,然后将酰胺与N -Boc偶联。-大号脯氨酸然后去保护。结果L已经证明,在纯净条件下,环戊酰胺基官能化的聚合物比其单体对应物具有明显更高的活性,可以在几种条件下用几种取代的苯甲醛将环酮醛醇缩合。通过使用15mol%的聚合物作为催化剂,直接的羟醛反应产物以高收率和良好的非对映和对映选择性被分离。基于圆二色性光谱分析,催化活性的增强可能与聚(2-恶唑啉)s的假肽支架的构象变化有关。另外,这些可溶性聚合物催化剂可通过在乙醚中沉淀五个催化循环而回收和再利用,而不会显着降低其效率。
    DOI:
    10.1039/c6cy00448b
  • 作为产物:
    参考文献:
    名称:
    Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation
    摘要:
    Strategies to inhibit kinases by targeting the substrate binding site offer many advantages, including naturally evolved selectivity filters, but normally suffer from poor potency. In this work we propose a strategy to design and prepare covalent substrate-competitive kinase inhibitors as a method to improve potency. We have chosen Ala as the model kinase for this work. Using the AKT-GSK3 beta cocrystal structure and a reactive cysteine near the substrate binding site, we have identified phenylalanine (Phe) as an appropriate scaffold for the covalent inactivator portion of these inhibitors. By synthesizing compounds that incorporate cysteine-reactive electrophiles into phenylalanine and testing these compounds as AKT inhibitors, we have identified Boc-Phe-vinyl ketone as a submicromolar inactivator of AKT. We also show that Boc-Phe-vinyl ketone (1) potently inhibits AKT1 and inhibits cell growth in HCT116 and H460 cells nearly as well as AKT inhibitors GSK690693 and MK-2206, (2) is selective for kinases that possess an activation loop cysteine such as AKT, (3) requires the vinyl ketone for inactivation, (4) has inactivation that is time-dependent, and (5) alkylates Cys310 of AKT as shown by mass spectrometry. Identification of Boc-Phe-vinyl ketone as a covalent inactivator of AKT will allow the development of peptide and small-molecule substrate-competitive covalent kinase inhibitors that incorporate additional substrate binding elements to increase selectivity and potency. This proof-of-principle study also provides a basis to apply this strategy to other kinases of the AGC and CAMK families.
    DOI:
    10.1021/ml500088x
点击查看最新优质反应信息

文献信息

  • Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation
    作者:Thuy Nguyen、Robert A. Coover、Jenson Verghese、Richard G. Moran、Keith C. Ellis
    DOI:10.1021/ml500088x
    日期:2014.5.8
    Strategies to inhibit kinases by targeting the substrate binding site offer many advantages, including naturally evolved selectivity filters, but normally suffer from poor potency. In this work we propose a strategy to design and prepare covalent substrate-competitive kinase inhibitors as a method to improve potency. We have chosen Ala as the model kinase for this work. Using the AKT-GSK3 beta cocrystal structure and a reactive cysteine near the substrate binding site, we have identified phenylalanine (Phe) as an appropriate scaffold for the covalent inactivator portion of these inhibitors. By synthesizing compounds that incorporate cysteine-reactive electrophiles into phenylalanine and testing these compounds as AKT inhibitors, we have identified Boc-Phe-vinyl ketone as a submicromolar inactivator of AKT. We also show that Boc-Phe-vinyl ketone (1) potently inhibits AKT1 and inhibits cell growth in HCT116 and H460 cells nearly as well as AKT inhibitors GSK690693 and MK-2206, (2) is selective for kinases that possess an activation loop cysteine such as AKT, (3) requires the vinyl ketone for inactivation, (4) has inactivation that is time-dependent, and (5) alkylates Cys310 of AKT as shown by mass spectrometry. Identification of Boc-Phe-vinyl ketone as a covalent inactivator of AKT will allow the development of peptide and small-molecule substrate-competitive covalent kinase inhibitors that incorporate additional substrate binding elements to increase selectivity and potency. This proof-of-principle study also provides a basis to apply this strategy to other kinases of the AGC and CAMK families.
  • Novel poly(2-oxazoline)s with pendant <scp>l</scp>-prolinamide moieties as efficient organocatalysts for direct asymmetric aldol reaction
    作者:Yao Wang、Huifang Shen、Le Zhou、Fangyu Hu、Shoulei Xie、Liming Jiang
    DOI:10.1039/c6cy00448b
    日期:——
    bearing amino groups in the side-chains followed by amide coupling with N-Boc-L-proline then deprotection. The resultant L-prolinamido-functionalized polymers have proven to be significantly more active than their monomeric counterparts for the aldolisation of cyclic ketones with several substituted benzaldehydes under neat conditions. By using 15 mol% of the polymer as a catalyst, the direct aldol reaction
    聚(2-恶唑啉)负载的双功能有机催化剂已通过自下而上的方法制备,该方法涉及合成明确定义的侧链中带有氨基的聚(2-恶唑啉)前体,然后将酰胺与N -Boc偶联。-大号脯氨酸然后去保护。结果L已经证明,在纯净条件下,环戊酰胺基官能化的聚合物比其单体对应物具有明显更高的活性,可以在几种条件下用几种取代的苯甲醛将环酮醛醇缩合。通过使用15mol%的聚合物作为催化剂,直接的羟醛反应产物以高收率和良好的非对映和对映选择性被分离。基于圆二色性光谱分析,催化活性的增强可能与聚(2-恶唑啉)s的假肽支架的构象变化有关。另外,这些可溶性聚合物催化剂可通过在乙醚中沉淀五个催化循环而回收和再利用,而不会显着降低其效率。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物